Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
What is the present valuation and projected CAGR of the tumor ablation market?
The tumor ablation market size has grown rapidly in recent years. It will grow from $1.45 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to the development of more precise and efficient ablation techniques, rising healthcare expenditure across emerging economies, the demographic shift towards older populations, the increasing burden of cancer, and the rising prevalence of cancer globally.
The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.54 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing cancer incidence, growing minimally invasive procedures, expanding applications, increasing healthcare cost-effectiveness, and growing awareness and education. Major trends in the forecast period include technological advancements, Continued development of advanced ablation technologies, integration of artificial intelligence, focus on outpatient settings, and patient-centric approaches.
Get Your Free Sample of The Global Tumor Ablation Market Report:
Tumor Ablation Market Report 2025
What key drivers have fueled the tumor ablation market’s development over the years?
The growth of minimally invasive procedures is expected to propel the growth of the tumor ablation market going forward. Minimally invasive procedures are medical or surgical interventions that require only small incisions or no incisions at all. The demand for minimally invasive procedures is on the rise due to their reduced recovery times, lower risk of complications, and lower post-operative pain compared to traditional surgeries. Tumor ablation is utilized in minimally invasive procedures to destroy cancerous tissues using techniques such as radiofrequency, microwave, or cryoablation, minimizing damage to surrounding healthy tissue and reducing recovery times. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, the growth of minimally invasive procedures is driving the growth of the tumor ablation market.
What is the segmentation for the tumor ablation market?
The tumor ablation market covered in this report is segmented –
1) By Type: Thermal Ablation, Chemical Ablation
2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer
4) By End Users: Hospitals, Oncology Centers, Other End Users
Subsegments:
1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)
2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)
Order your report now for swift delivery
Tumor Ablation Market Report 2025
Who are the most influential companies in the tumor ablation market?
Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.
What are the top industry trends projected to impact the tumor ablation market?
Major companies operating in the tumor ablation market are developing innovative products, such as bone tumor ablation systems, to enhance treatment efficacy, improve patient outcomes, and expand the range of treatable tumors. A bone tumor ablation system is a specialized medical device used to treat bone tumors through minimally invasive procedures. For instance, in March 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2.bone tumor ablation system. The upgraded system is designed to treat painful bone metastases and benign bone tumors such as osteoi osteoma. The OsteoCool 2.0 allows for the simultaneous use of four internally cooled probes, enabling physicians to ablate two vertebral bodies at once or create larger ablation zones in extra-spinal applications. It delivers 20W per channel, more than twice the power of the Stryker OptaBlate bone tumor ablation system.
What are the major regional insights for the tumor ablation market, and which region holds the top position?
North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Tumor Ablation Market Report 2025 Offer?
The tumor ablation market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Tumor ablation is a minimally invasive medical procedure used to destroy cancerous tissues. It involves the application of extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This technique is often employed for small tumors or those in difficult-to-reach locations.
Purchase the exclusive report now to unlock valuable market insights:
Tumor Ablation Market Report 2025
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Twitter: The Business Research Company (@tbrc_info) on X
Facebook: The Business Research Company | London
YouTube: The Business Research Company
Blog: Fructooligosaccharides Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities – Latest Global Market Insights
Healthcare Blog: Latest Healthcare Research Reports – By The Business Research Company
Global Market Model: Global Market Intelligence Database
